ISV-403

Thuốc Gốc

Small Molecule

ISV-403 combines a fourth-generation fluoroquinolone, SS734, licensed from Japan's SSP, Co., Ltd., with InSite Vision's patented drug delivery system, DuraSite(R). Preclinical studies with ISV-403 indicated that this drug candidate is effective against bacteria resistant to third generation fluoroquinolone products.

Cơ Chế Tác Dụng : ISV-403 combines a fourth-generation fluoroquinolone, SS734, licensed from Japan's SSP, Co., Ltd., with InSite Vision's patented drug delivery system, DuraSite(R). Preclinical studies with ISV-403 indicated that this drug candidate is effective against bacteria resistant to third generation fluoroquinolone products. ISV-403, an ophthalmic pharmaceutical product for the treatment of ocular bacterial infections. ISV-403 has equal to or superior attributes for broad-spectrum activity and could provide for lower dosing frequencies than comparable products. Lowering dosing frequencies could improve patient compliance, which can be a serious issue in treating ocular infections.

Chỉ Định : Investigated for use/treatment in eye disorders/infections.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05862

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading